Notice Number: NOT-HL-12-001
Release Date: January 10, 2012
National Heart, Lung, and Blood Institute (NHLBI)
On July 22, 2011, NHLBI issued a Notice (NOT-HL-11-154) in the NIH Guide discontinuing its participation in the Parent R21 Funding Opportunity Announcement (FOA). In brief, NHLBI will not accept any “new” R21s beginning with the 10/16/11 due date and beyond. However, the Institute will continue to accept resubmission (A1) R21 applications for the 3/16/12 due date for non-AIDS and for the 5/7/12 due date for AIDS R21s.
Since PA-10-069 has expired, NHLBI will participate in PA-11-261 for cycle I in 2012 in order to allow assignment of resubmission (A1) R21s to NHLBI for primary funding consideration. NHLBI will not accept any “new” (A0) R21 applications in response to the Parent R21 FOA (PA-11-261). Once cycle I (March 16/May 7) 2012 submissions are done, NHLBI will not accept any investigator-initiated R21 applications in response to PA-11-261.
All other aspects of PA-11-261 remain unchanged.
For general information and questions regarding the R21 program, individuals are encouraged to contact the appropriate scientific program Division within the NHLBI.
Interested parties may contact:
Division of Cardiovascular Diseases
Dr. Michael Lauer
Two Rockledge Center, Room 8124
6701 Rockledge Drive, MSC 7940
Bethesda, MD 20892-7940
Dr. James Kiley
Two Rockledge Center, Room 10042
6701 Rockledge Drive, MSC 7952
Bethesda, MD 20892-7952
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
Office of Extramural
National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
Department of Health
and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.